Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Trang H. Au"'
Autor:
David D. Stenehjem, Siripa Udomaksorn, Yan Cheng, Lance Pflieger, Trang H. Au, Saundra S. Buys, Diana I. Brixner
Publikováno v:
Cogent Medicine, Vol 3, Iss 1 (2016)
Background: The increasing number of available cancer therapies render medical decision-making (MDM) less straightforward. Patients want to know about the outcomes of similarly treated patients. Objective: The goal of this study was to design a breas
Externí odkaz:
https://doaj.org/article/92c5e4eb80664269a7b54bfd31262e34
Autor:
Trang H Au, Connor Willis, Maija Reblin, Katherine B Peters, Phioanh Leia Nghiemphu, Jennie W Taylor, Howard Colman, Adam L Cohen, David Ryan Ormond, Elizabeth C Neil, Arnab Chakravarti, Nicole Willmarth, Bea Christine Balajonda, Jyothi Menon, Junjie Ma, Hillevi Bauer, Ryan S Nelson, Malinda S Tan, Prianka Singh, Alexander Marshall, Beata Korytowsky, David Stenehjem, Diana Brixner
Publikováno v:
Future Oncology. 19:173-188
Aim: To develop a cognitive dysfunction (CD) focused questionnaire to evaluate caregiver burden in glioblastoma. Materials & methods: The survey was developed from stakeholder consultations and a pilot study, and disseminated at eight US academic can
Autor:
David D Stenehjem, Andrew W Hahn, David M Gill, Daniel Albertson, Banumathy Gowrishankar, Joseph Merriman, Archana M Agarwal, Venkata Thodima, Erik B Harrington, Trang H Au, Benjamin L Maughan, Jane Houldsworth, Sumanta K Pal, Neeraj Agarwal
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210415 (2019)
BACKGROUND:First-line treatment for metastatic renal cell carcinoma (mRCC) is rapidly changing. It currently includes VEGF targeted therapies (TT), multi-target tyrosine kinase inhibitors (TKIs), mTOR inhibitors, and immunotherapy. To optimize outcom
Externí odkaz:
https://doaj.org/article/772ff832c27e41e58c93b091941976b8
Autor:
Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, David Stenehjem
Publikováno v:
Oncotarget
Background: Tumor mutational burden (TMB) is a potential biomarker to predict tumor response to immuno-oncology agents in patients with metastatic non-small cell lung cancer (NSCLC). Materials and Methods: A multi-site cohort study evaluated patients
Autor:
Phioanh L. Nghiemphu, D. Ryan Ormond, Adam L. Cohen, Diana I. Brixner, Katherine B. Peters, Nicole Willmarth, Beata Korytowsky, Prianka Singh, Connor Willis, Trang H. Au, Cornelia M. Ulrich, Alexandre H. Watanabe, Arnab Chakravarti, Jyothi Menon, Alexander Marshall, Hillevi Bauer, David D. Stenehjem, Junjie Ma, Jennie Taylor, Maija Reblin, Howard Colman
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol 30, iss 2
Supportive Care in Cancer
Supportive Care in Cancer
Background Glioblastoma is an incurable disease with a poor prognosis. For caregivers of people with glioblastoma, the burden of care can be high. Patients often present with different clinical characteristics, which may impact caregiver burden in di
Publikováno v:
Journal of managed carespecialty pharmacy. 27(10)
BACKGROUND: Pancreatic cancer is associated with low median overall survival. Combination chemotherapy regimens FOLFIRINOX and gemcitabine with nab-paclitaxel (GemNab) are the new adjuvant treatment standards for resectable pancreatic cancer. PRODIGE
Autor:
Jyothi Menon, Junjie Ma, Phioanh L. Nghiemphu, Jennie Taylor, David D. Stenehjem, Alexander Marshall, Maija Reblin, Trang H. Au, Adam L. Cohen, Nicole Willmarth, Diana I. Brixner, Cornelia M. Ulrich, Alexandre H. Watanabe, Prianka Singh, Beata Korytowsky, Arnab Chakravarti, Connor Willis, Hillevi Bauer, D. Ryan Ormond, Howard Colman, Katherine B. Peters
Publikováno v:
Supportive Care in Cancer
Glioblastoma is an incurable disease with a poor prognosis. For caregivers of people with glioblastoma, the burden of care can be high. Patients often present with different clinical characteristics, which may impact caregiver burden in different way
Autor:
Zachary Rivers, Trang H. Au, Cornelia M. Ulrich, David D. Stenehjem, Diana I. Brixner, Brandon S. Walker, Eman Biltaji, Jennifer Ose, Christopher I. Li
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Inherited genetic variants can modify the cancer-chemopreventive effect of aspirin. We evaluated the clinical and economic value of genotype-guided aspirin use for colorectal cancer chemoprevention in average-risk individuals. Methods: A
Autor:
Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, David Stenehjem
Publikováno v:
Oncotarget. 13:1306-1306
Autor:
Trang H. Au, Rupesh Panchal, Madeline Brendle, Aditi Kharat, Sabrina Ilham, David Huggar, Diana I. Brixner, Ali McBride, Ronda Copher, Connor Willis
Publikováno v:
Journal of Clinical Oncology. 39:46-46
46 Background: Alternative payment models (APMs) aim to address the rising cost of cancer care ($173 billion in 2020) by promoting high-value care. This study explored the challenges and opportunities associated with implementation of APMs in oncolog